Clinical Trials for Amyotrophic Lateral Sclerosis

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

NCT ID: NCT06126315

This clinical trial is studying the effects of a treatment called acetyl-L-carnitine (ALCAR) on people with amyotrophic lateral sclerosis (ALS), a disease that affects the nerves and can lead to lo...

Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis

NCT ID: NCT05979688

This clinical trial is exploring how a 6-week online program of yogic breathing exercises might help improve breathing, speech, and emotional well-being in people living with amyotrophic lateral sc...

RAPA-501 Therapy for ALS

NCT ID: NCT04220190

The RAPA-501 Therapy for ALS trial is studying a new treatment for people living with amyotrophic lateral sclerosis (ALS), a serious condition that affects muscle control. This trial is looking at ...

High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project

NCT ID: NCT06881979

This clinical trial, called the Fit4MedRob-Chronic MND Project, is looking at how effective high-tech rehabilitation treatments are for patients with chronic neuromuscular diseases like Amyotrophic...

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

NCT ID: NCT06008249

This clinical trial is studying the effectiveness of various drugs for people with Amyotrophic Lateral Sclerosis (ALS), a progressive disease that affects nerve cells in the brain and spinal cord. ...

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

NCT ID: NCT03225144

This clinical trial is focused on understanding complex neurodegenerative disorders, particularly those related to conditions like Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (A...

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

NCT ID: NCT05633459

This clinical trial is studying a new treatment called QRL-201 for people living with Amyotrophic Lateral Sclerosis (ALS), a condition that affects the nerves and muscles. The main goal of the stud...

Neurologic Stem Cell Treatment Study

NCT ID: NCT02795052

The Neurologic Stem Cell Treatment Study is exploring a new way to help people with various neurologic disorders, such as Parkinson's disease, Alzheimer's, and traumatic brain injuries. The study i...

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

NCT ID: NCT02327845

Phenotype, Genotype and Biomarkers 2

NCT ID: NCT04875416

The "Phenotype, Genotype and Biomarkers 2" study is focused on understanding more about amyotrophic lateral sclerosis (ALS) and other related neurological diseases like frontotemporal dementia (FTD...

Clinical Procedures to Support Research in ALS

NCT ID: NCT03489278

The CAPTURE study is a research project aimed at understanding more about amyotrophic lateral sclerosis (ALS) and similar conditions. By looking at information collected from patients' medical reco...

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

NCT ID: NCT05744310

This clinical trial is studying how long-term ventilation support affects the quality of life for patients with Amyotrophic Lateral Sclerosis (ALS) and their families. ALS is a serious disease that...

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

NCT ID: NCT06973629

The ENDURANCE STUDY is a clinical trial designed to test a treatment called NurOwn (Debamestrocel) for people with early symptoms of Amyotrophic Lateral Sclerosis (ALS), a condition that affects th...

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

NCT ID: NCT04097158

This clinical trial is studying how a medication called Edaravone (also known as Radicava) works in different types of patients with Amyotrophic Lateral Sclerosis (ALS). The researchers want to fin...

Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis

NCT ID: NCT06083584

This clinical trial is looking at a new way to diagnose Amyotrophic Lateral Sclerosis (ALS) by analyzing RNA, which is a molecule that helps carry information from DNA to make proteins in the body....

Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.

NCT ID: NCT06228001

The clinical trial titled "Holter of Movement in Patients With Amyotrophic Lateral Sclerosis" is studying how movement in patients with amyotrophic lateral sclerosis (ALS) can be monitored over tim...

Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis

NCT ID: NCT05352958

This clinical trial is studying a new way to monitor how well the diaphragm is working in patients with Amyotrophic Lateral Sclerosis (ALS), a serious disease that affects muscle control. The diaph...

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

NCT ID: NCT06656702

This clinical trial is exploring the use of psilocybin, a compound found in certain mushrooms, as a potential therapy for patients with Amyotrophic Lateral Sclerosis (ALS) who also experience depre...

Analysis of Human ALS Tissues and Registry of ALS Patients

NCT ID: NCT05067179

This clinical trial is focused on understanding Amyotrophic Lateral Sclerosis (ALS), a serious condition that leads to muscle weakness and is caused by the degeneration of nerve cells in the brain ...

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

NCT ID: NCT04057898

This clinical trial is studying a medication called MN-166 (ibudilast) to see if it can help patients with Amyotrophic Lateral Sclerosis (ALS) over a period of 12 months, followed by an additional ...